This guidance requires that clinicians undertaking the epithelium‑on (transepithelial) corneal collagen cross‑linkage (CXL) and combination (CXL‑plus) procedures make special arrangements for audit. NICE has identified relevant audit criteria and has developed an audit tool (which is for use at local discretion).
The evidence considered by the Interventional Procedures Advisory Committee is described in the systematic review and its addendum.
NICE has produced information for the public on these procedures. It explains the nature of the procedures and the guidance issued by NICE, and has been written with patient consent in mind.
ISBN: 978-1-4731-0288-0